{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T04:02:04Z","timestamp":1790308924779,"version":"4.1.0"},"reference-count":31,"publisher":"American Medical Association (AMA)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"DOI":"10.1001\/jamanetworkopen.2022.4488","type":"journal-article","created":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T20:04:17Z","timestamp":1648670657000},"page":"e224488","source":"Crossref","is-referenced-by-count":77,"title":["Analysis of Adverse Events and Intravenous Iron Infusion Formulations in Adults With and Without Prior Infusion Reactions"],"prefix":"10.1001","volume":"5","author":[{"given":"Asad H.","family":"Arastu","sequence":"first","affiliation":[{"name":"Department of Medicine, Oregon Health & Science University, Portland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin K.","family":"Elstrott","sequence":"additional","affiliation":[{"name":"Department of Medicine, Oregon Health & Science University, Portland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kylee L.","family":"Martens","sequence":"additional","affiliation":[{"name":"Department of Hematology-Oncology, Knight Cancer Institute, Oregon Health & Science University, Portland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan L.","family":"Cohen","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Oregon Health & Science University, Portland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael H.","family":"Oakes","sequence":"additional","affiliation":[{"name":"Department of Medicine, Oregon Health & Science University, Portland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhoe T.","family":"Rub","sequence":"additional","affiliation":[{"name":"Department of Medicine, Chicago Medical School at Rosalind Franklin University of Medicine and Science, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph E.","family":"Aslan","sequence":"additional","affiliation":[{"name":"Department of Biomedical Engineering, Oregon Health & Science University, Portland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas G.","family":"DeLoughery","sequence":"additional","affiliation":[{"name":"Department of Hematology-Oncology, Knight Cancer Institute, Oregon Health & Science University, Portland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Shatzel","sequence":"additional","affiliation":[{"name":"Department of Hematology-Oncology, Knight Cancer Institute, Oregon Health & Science University, Portland"},{"name":"Department of Biomedical Engineering, Oregon Health & Science University, Portland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2022,3,30]]},"reference":[{"issue":"7","key":"zoi220155r1","doi-asserted-by":"publisher","first-page":"3619","DOI":"10.4103\/jfmpc.jfmpc_559_20","article-title":"Oral versus intravenous iron therapy in iron deficiency anemia: an observational study.","volume":"9","author":"Das","year":"2020","journal-title":"J Family Med Prim Care"},{"issue":"6","key":"zoi220155r2","doi-asserted-by":"publisher","first-page":"461","DOI":"10.5581\/1516-8484.20110123","article-title":"Intravenous iron therapy: how far have we come?","volume":"33","author":"Can\u00e7ado","year":"2011","journal-title":"Rev Bras Hematol Hemoter"},{"issue":"4","key":"zoi220155r3","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1055\/s-0038-1668555","article-title":"Treatment of iron deficiency anemia in pregnancy with intravenous versus oral iron: systematic review and meta-analysis.","volume":"36","author":"Govindappagari","year":"2019","journal-title":"Am J Perinatol"},{"issue":"2","key":"zoi220155r4","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1080\/14740338.2018.1400009","article-title":"The safety of available treatment options for iron-deficiency anemia.","volume":"17","author":"Mu\u00f1oz","year":"2018","journal-title":"Expert Opin Drug Saf"},{"issue":"2","key":"zoi220155r5","first-page":"137","article-title":"Prevention and management of acute reactions to intravenous iron in surgical patients.","volume":"17","author":"G\u00f3mez-Ram\u00edrez","year":"2019","journal-title":"Blood Transfus"},{"issue":"1","key":"zoi220155r6","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.kint.2015.10.002","article-title":"Iron management in chronic kidney disease: conclusions from a \u201cKidney Disease: Improving Global Outcomes\u201d (KDIGO) Controversies Conference.","volume":"89","author":"Macdougall","year":"2016","journal-title":"Kidney Int"},{"issue":"1","key":"zoi220155r7","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.mayocp.2014.10.007","article-title":"The safety of intravenous iron preparations: systematic review and meta-analysis.","volume":"90","author":"Avni","year":"2015","journal-title":"Mayo Clin Proc"},{"issue":"3","key":"zoi220155r8","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1111\/ejh.v104.3","article-title":"The role of iron repletion in adult iron deficiency anemia and other diseases.","volume":"104","author":"Elstrott","year":"2020","journal-title":"Eur J Haematol"},{"issue":"2","key":"zoi220155r9","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1093\/ndt\/gfi253","article-title":"Update on adverse drug events associated with parenteral iron.","volume":"21","author":"Chertow","year":"2006","journal-title":"Nephrol Dial Transplant"},{"issue":"11","key":"zoi220155r10","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.3324\/haematol.2014.111492","article-title":"Hypersensitivity reactions to intravenous iron: guidance for risk minimization and management.","volume":"99","author":"Rampton","year":"2014","journal-title":"Haematologica"},{"issue":"1","key":"zoi220155r11","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1159\/000451069","article-title":"Complement activation-related pseudo-allergy: a fresh look at hypersensitivity reactions to intravenous iron.","volume":"45","author":"Macdougall","year":"2017","journal-title":"Am J Nephrol"},{"issue":"19","key":"zoi220155r12","doi-asserted-by":"publisher","first-page":"2062","DOI":"10.1001\/jama.2015.15572","article-title":"Comparative risk of anaphylactic reactions associated with intravenous iron products.","volume":"314","author":"Wang","year":"2015","journal-title":"JAMA"},{"key":"zoi220155r13","doi-asserted-by":"publisher","first-page":"S83","DOI":"10.1111\/hdi.12560","article-title":"The available intravenous iron formulations: history, efficacy, and toxicology.","volume":"21","author":"Auerbach","year":"2017","journal-title":"Hemodial Int"},{"issue":"12","key":"zoi220155r14","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1002\/ajh.v95.12","article-title":"A multicenter study evaluating the effectiveness and safety of single-dose low molecular weight iron dextran vs single-dose ferumoxytol for the treatment of iron deficiency.","volume":"95","author":"Cohen","year":"2020","journal-title":"Am J Hematol"},{"issue":"7","key":"zoi220155r15","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1002\/ajh.v83:7","article-title":"Intravenous iron: from anathema to standard of care.","volume":"83","author":"Auerbach","year":"2008","journal-title":"Am J Hematol"},{"issue":"3","key":"zoi220155r16","first-page":"224","article-title":"Immunologic studies of anaphylaxis to iron dextran in patients on renal dialysis.","volume":"72","author":"Novey","year":"1994","journal-title":"Ann Allergy"},{"issue":"3","key":"zoi220155r17","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.iac.2014.04.013","article-title":"Hypersensitivity from intravenous iron products.","volume":"34","author":"Bircher","year":"2014","journal-title":"Immunol Allergy Clin North Am"},{"issue":"6","key":"zoi220155r18","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1615\/CritRevTherDrugCarrierSyst.v18.i6","article-title":"Complement activation-related pseudoallergy caused by liposomes, micellar carriers of intravenous drugs, and radiocontrast agents.","volume":"18","author":"Szebeni","year":"2001","journal-title":"Crit Rev Ther Drug Carrier Syst"},{"issue":"1","key":"zoi220155r19","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1159\/000451060","article-title":"Distinct in vitro complement activation by various intravenous iron preparations.","volume":"45","author":"Hempel","year":"2017","journal-title":"Am J Nephrol"},{"issue":"8","key":"zoi220155r20","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1093\/ibd\/izy063","article-title":"Adverse reactions after intravenous iron infusion among inflammatory bowel disease patients in the United States, 2010-2014.","volume":"24","author":"Akhuemonkhan","year":"2018","journal-title":"Inflamm Bowel Dis"},{"issue":"6","key":"zoi220155r21","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1093\/ndt\/gfh185","article-title":"On the relative safety of parenteral iron formulations.","volume":"19","author":"Chertow","year":"2004","journal-title":"Nephrol Dial Transplant"},{"issue":"11","key":"zoi220155r22","doi-asserted-by":"publisher","first-page":"E123","DOI":"10.1002\/ajh.v87.11","article-title":"Comparative rates of adverse events with different formulations of intravenous iron.","volume":"87","author":"Okam","year":"2012","journal-title":"Am J Hematol"},{"issue":"4","key":"zoi220155r23","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1080\/08860220701278208","article-title":"Is there a difference between the allergic potencies of the iron sucrose and low molecular weight iron dextran?","volume":"29","author":"Sav","year":"2007","journal-title":"Ren Fail"},{"issue":"10","key":"zoi220155r24","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1002\/ajh.22153","article-title":"Safety and efficacy of rapidly administered (one hour) one gram of low molecular weight iron dextran (INFeD) for the treatment of iron deficient anemia.","volume":"86","author":"Auerbach","year":"2011","journal-title":"Am J Hematol"},{"issue":"1","key":"zoi220155r25","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1111\/tatm.2007.9.issue-1","article-title":"Tolerability and efficacy of parenteral iron therapy in hemodialysis patients, a comparison of preparations.","volume":"9","author":"Moniem","year":"2007","journal-title":"Transfus Altern Transfus Med"},{"issue":"1","key":"zoi220155r26","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/tatm.2007.9.issue-1","article-title":"Adverse events associated with intravenous iron infusion (low-molecular-weight iron dextran and iron sucrose): a systematic review.","volume":"9","author":"Critchley","year":"2007","journal-title":"Transfus Altern Transfus Med"},{"issue":"5","key":"zoi220155r27","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1002\/ajh.25060","article-title":"Comparative safety of intravenous ferumoxytol versus ferric carboxymaltose in iron deficiency anemia: a randomized trial.","volume":"93","author":"Adkinson","year":"2018","journal-title":"Am J Hematol"},{"issue":"21","key":"zoi220155r29","doi-asserted-by":"publisher","first-page":"5025","DOI":"10.1111\/bph.2015.172.issue-21","article-title":"Hypersensitivity to intravenous iron: classification, terminology, mechanisms and management.","volume":"172","author":"Szebeni","year":"2015","journal-title":"Br J Pharmacol"},{"issue":"1","key":"zoi220155r30","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/S0002-9343(00)00396-X","article-title":"Intravenous iron dextran therapy in patients with iron deficiency and normal renal function who failed to respond to or did not tolerate oral iron supplementation.","volume":"109","author":"Barton","year":"2000","journal-title":"Am J Med"},{"issue":"4","key":"zoi220155r31","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1016\/j.jaip.2020.11.028","article-title":"Safety of intravenous iron following infusion reactions.","volume":"9","author":"Stojanovic","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"zoi220155r28","unstructured":"European Medicines Agency. New recommendations to manage risk of allergic reactions with intravenous iron-containing medicines, 2013. Accessed February 17, 2022. https:\/\/www.ema.europa.eu\/en\/documents\/referral\/intravenous-iron-containing-medicinal-products-article-31-referral-new-recommendations-manage-risk_en.pdf"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2790508\/arastu_2022_oi_220155_1655137433.99957.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,22]],"date-time":"2022-06-22T15:00:48Z","timestamp":1655910048000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2790508"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,30]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.4488","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,30]]}}}